Chromogranin A as a biomarker for prostate cancer: is it actually relevant for clinical practice?

被引：6
作者：
Appetecchia, Marialuisa [1 ]
Lauretta, Rosa [1 ]
Sperduti, Isabella [2 ]
Gallucci, Michele [3 ]
机构：
[1] Regina Elena Inst Canc Res, Endocrinol Unit, Rome, Italy
[2] Regina Elena Inst Canc Res, Biostat Unit, Rome, Italy
[3] Regina Elena Inst Canc Res, Urol Unit, Rome, Italy
来源：
FUTURE ONCOLOGY | 2018年 / 14卷 / 13期
关键词：
ABIRATERONE THERAPY; SERUM-LEVELS; PROGRESSION; PREDICTION;
D O I：
10.2217/fon-2018-0025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1233 / 1235
页数：3
相关论文
共 10 条
[1]   Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma [J].
Appetecchia, Marialuisa ;
Mecule, Aurela ;
Pasimeni, Giuseppe ;
Iannucci, Concetta V. ;
De Carli, Piero ;
Baldelli, Roberto ;
Barnabei, Agnese ;
Cigliana, Giovanni ;
Sperduti, Isabella ;
Gallucci, Michele .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
[2]   Genomic Markers in Prostate Cancer Decision Making [J].
Cucchiara, Vito ;
Cooperberg, Matthew R. ;
Dall'Era, Marc ;
Lin, Daniel W. ;
Montorsi, Francesco ;
Schalken, Jack A. ;
Evans, Christopher P. .
EUROPEAN UROLOGY, 2018, 73 (04) :572-582
[3]   Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: Results from an Italian biopsy cohort [J].
De Nunzio, Cosimo ;
Albisinni, Simone ;
Presicce, Fabrizio ;
Lombardo, Riccardo ;
Cancrini, Fabiana ;
Tubaro, Andrea .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (02) :80-84
[4]  
Esfahani Maryam, 2015, Asian Pac J Cancer Prev, V16, P2601
[5]   Chromogranin A and neurone-specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer [J].
Fan, Liancheng ;
Wang, Yanqing ;
Chi, Chenfei ;
Pan, Jiahua ;
Xun, Shangguan ;
Xin, Zhixiang ;
Hu, Jianian ;
Zhou, Lixin ;
Dong, Baijun ;
Xue, Wei .
BJU INTERNATIONAL, 2017, 120 (02) :226-232
[6]   Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine? [J].
Grigore, Alexandru Dan ;
Ben-Jacob, Eshel ;
Farach-Carson, Mary C. .
FRONTIERS IN ONCOLOGY, 2015, 5
[7]   Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy [J].
Heck, Matthias M. ;
Thaler, Markus A. ;
Schmid, Sebastian C. ;
Seitz, Anna-Katharina ;
Tauber, Robert ;
Kuebler, Hubert ;
Maurer, Tobias ;
Thalgott, Mark ;
Hatzichristodoulou, Georgios ;
Hoeppner, Michael ;
Nawroth, Roman ;
Luppa, Peter B. ;
Gschwend, Juergen E. ;
Retz, Margitta .
BJU INTERNATIONAL, 2017, 119 (01) :30-37
[8]  
Mitsui Y, 2015, UROL J, V12, P2165
[9]   Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival [J].
Niedworok, Christian ;
Tschirdewahn, Stephan ;
Reis, Henning ;
Lehmann, Nils ;
Szuecs, Miklos ;
Nyirady, Peter ;
Romics, Imre ;
Ruebben, Herbert ;
Szarvas, Tibor .
PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (03) :643-650
[10]   Urinary biomarkers in prostate cancer detection and monitoring progression [J].
Wu, Duojia ;
Ni, Jie ;
Beretov, Julia ;
Cozzi, Paul ;
Willcox, Mark ;
Wasinger, Valerie ;
Walsh, Bradley ;
Graham, Peter ;
Li, Yong .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 118 :15-26
1